Predictors for clinical trial participation in the rare lung disease lymphangioleiomyomatosis.

PubWeight™: 0.77‹?›

🔗 View Article (PMC 4407662)

Published in Respir Med on December 04, 2009

Authors

Brent W Kinder1, A C Sherman, L R Young, J T Hagaman, N Oprescu, S Byrnes, Francis X McCormack

Author Affiliations

1: Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA. brent.kinder@uc.edu

Associated clinical trials:

Efficacy and Safety of Sirolimus for Treating Lymphangioleiomyomatosis (LAM) | NCT00414648

Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM) (EXIST-2) | NCT00790400

Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM | NCT00457808

RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAM | NCT00457964

Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM) | NCT00792766

Treatment With Octreotide in Patients With Lymphangioleiomyomatosis | NCT00005906

Articles cited by this

Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med (2008) 9.64

Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors. Lancet Oncol (2006) 4.32

The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment. Am J Respir Crit Care Med (2005) 4.15

Lymphangioleiomyomatosis: a clinical update. Chest (2008) 3.79

Clinical research for rare disease: opportunities, challenges, and solutions. Mol Genet Metab (2008) 2.91

A systematic review highlights threats to validity in studies of barriers to cancer trial participation. J Clin Epidemiol (2007) 2.20

Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P). Medicine (Baltimore) (1999) 2.11

Factors influencing inclusion of patients with malignancies in clinical trials. Cancer (2006) 1.76

Molecular pathogenesis of lymphangioleiomyomatosis: lessons learned from orphans. Am J Respir Cell Mol Biol (2006) 1.47

Survival and disease progression in UK patients with lymphangioleiomyomatosis. Thorax (2004) 1.32

Reasons for participation and non-participation in a randomized controlled trial: postal questionnaire surveys of women eligible for TOMBOLA (Trial Of Management of Borderline and Other Low-Grade Abnormal smears). Clin Trials (2006) 1.31

Management of pneumothorax in lymphangioleiomyomatosis: effects on recurrence and lung transplantation complications. Chest (2006) 1.29

Prognostic significance of pulmonary lymphangioleiomyomatosis histologic score. Am J Surg Pathol (2001) 1.15

Sex differences in perceived risks, distrust, and willingness to participate in clinical trials: a randomized study of cardiovascular prevention trials. Arch Intern Med (2007) 1.12

Willingness of gynecologic cancer patients to participate in clinical trials. Gynecol Oncol (2008) 0.97

Barriers and motivations for women to participate in cardiovascular trials. J Obstet Gynaecol Can (2008) 0.92

Patient perspectives on management of pneumothorax in lymphangioleiomyomatosis. Chest (2006) 0.80

Articles by these authors

(truncated to the top 100)

Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med (2008) 9.64

The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment. Am J Respir Crit Care Med (2005) 4.15

Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism. Am J Respir Crit Care Med (2002) 2.56

Diffuse cystic lung disease at high-resolution CT. AJR Am J Roentgenol (2011) 2.31

Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability. J Clin Invest (2003) 2.16

Cutting edge: the immunostimulatory activity of the lung surfactant protein-A involves Toll-like receptor 4. J Immunol (2002) 1.92

Lymphangioleiomyomatosis - a wolf in sheep's clothing. J Clin Invest (2012) 1.87

The use of a postoperative morbidity survey to evaluate patients with prolonged hospitalization after routine, moderate-risk, elective surgery. Anesth Analg (1999) 1.81

Serum VEGF-D a concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trial. Lancet Respir Med (2013) 1.69

Neutrophil elastase increases MUC5AC mRNA and protein expression in respiratory epithelial cells. Am J Physiol (1999) 1.64

Moving visual scenes influence the apparent direction of gravity. Science (1972) 1.62

Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases. Chest (2010) 1.52

Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis. Chest (2009) 1.50

The physiological range of pressure difference and cupula deflections in the human semicircular canal. Theoretical considerations. Acta Otolaryngol (1972) 1.49

Molecular pathogenesis of lymphangioleiomyomatosis: lessons learned from orphans. Am J Respir Cell Mol Biol (2006) 1.47

Crystal structure of trimeric carbohydrate recognition and neck domains of surfactant protein A. J Biol Chem (2003) 1.37

Diagnostic potential of serum VEGF-D for lymphangioleiomyomatosis. N Engl J Med (2008) 1.30

Management of pneumothorax in lymphangioleiomyomatosis: effects on recurrence and lung transplantation complications. Chest (2006) 1.29

Air travel in women with lymphangioleiomyomatosis. Thorax (2006) 1.27

Perceived visual motion as effective stimulus to pursuit eye movement system. Science (1975) 1.25

Subjective detection of vertical acceleration: a velocity-dependent response? Acta Otolaryngol (1978) 1.24

Perception of linear horizontal self-motion induced by peripheral vision (linearvection) basic characteristics and visual-vestibular interactions. Exp Brain Res (1975) 1.24

A multidimensional model of the effect of gravity on the spatial orientation of the monkey. J Vestib Res (1993) 1.23

Pulmonary surfactant protein A up-regulates activity of the mannose receptor, a pattern recognition receptor expressed on human macrophages. J Immunol (2002) 1.23

Lymphangioleiomyomatosis: new concepts in pathogenesis, diagnosis, and treatment. Semin Respir Crit Care Med (2012) 1.20

Susceptibility of Hermansky-Pudlak mice to bleomycin-induced type II cell apoptosis and fibrosis. Am J Respir Cell Mol Biol (2007) 1.20

Utility of [18F]2-fluoro-2-deoxyglucose-PET in sporadic and tuberous sclerosis-associated lymphangioleiomyomatosis. Chest (2009) 1.19

Lung-restricted macrophage activation in the pearl mouse model of Hermansky-Pudlak syndrome. J Immunol (2006) 1.18

Influence of combined visual and vestibular cues on human perception and control of horizontal rotation. Exp Brain Res (1981) 1.16

Vestibular nucleus units in alert monkeys are also influenced by moving visual fields. Brain Res (1974) 1.11

Pulmonary surfactant protein a inhibits macrophage reactive oxygen intermediate production in response to stimuli by reducing NADPH oxidase activity. J Immunol (2004) 1.11

Pulmonary manifestations of Birt-Hogg-Dubé syndrome. Fam Cancer (2013) 1.10

Antimicrobial activity of native and synthetic surfactant protein B peptides. J Immunol (2006) 1.10

The alveolar epithelium determines susceptibility to lung fibrosis in Hermansky-Pudlak syndrome. Am J Respir Crit Care Med (2012) 1.06

Lymphangioleiomyomatosis screening in women with tuberous sclerosis. Chest (2013) 1.05

Optimal estimator model for human spatial orientation. Ann N Y Acad Sci (1988) 1.03

Comparative signature-tagged mutagenesis identifies Pseudomonas factors conferring resistance to the pulmonary collectin SP-A. PLoS Pathog (2005) 1.03

Bordetella pertussis lipopolysaccharide resists the bactericidal effects of pulmonary surfactant protein A. J Immunol (2004) 1.03

A revised dynamic otolith model. Aerosp Med (1968) 1.03

Model for vestibular adaptation to horizontal rotation. Aerosp Med (1969) 1.01

The etiology of ski injuries: an eight year study of the skier and his equipment. Orthop Clin North Am (1976) 1.01

Eye-movement measurement techniques. Am Psychol (1975) 1.01

Review: Structural determinants of pattern recognition by lung collectins. Innate Immun (2010) 0.99

Clinical predictors of mortality and cause of death in lymphangioleiomyomatosis: a population-based registry. Lung (2012) 0.98

Correction of pulmonary abnormalities in Sftpd-/- mice requires the collagenous domain of surfactant protein D. J Biol Chem (2006) 0.98

The resident scholar program: a research training opportunity for internal medicine house staff. J Cancer Educ (2007) 0.98

Spatial orientation in weightlessness and readaptation to earth's gravity. Science (1984) 0.97

Altered energy metabolism in anorexia nervosa. Psychoneuroendocrinology (2001) 0.95

Keratinocyte growth factor augments pulmonary innate immunity through epithelium-driven, GM-CSF-dependent paracrine activation of alveolar macrophages. J Biol Chem (2011) 0.95

Surfactant protein A is a principal and oxidation-sensitive microbial permeabilizing factor in the alveolar lining fluid. J Biol Chem (2005) 0.94

The flagellum of Pseudomonas aeruginosa is required for resistance to clearance by surfactant protein A. PLoS One (2007) 0.94

On the predictive control of foveal eye tracking and slow phases of optokinetic and vestibular nystagmus. J Physiol (1984) 0.94

Use of variability in national and regional data to estimate the prevalence of lymphangioleiomyomatosis. QJM (2011) 0.92

Birt-Hogg-Dubé syndrome. Fam Cancer (2013) 0.91

Mutagenesis of surfactant protein D informed by evolution and x-ray crystallography enhances defenses against influenza A virus in vivo. J Biol Chem (2011) 0.91

The vestibulo-ocular reflex of the squirrel monkey during eccentric rotation and roll tilt. Exp Brain Res (1995) 0.90

Neither SP-A nor NH2-terminal domains of SP-A can substitute for SP-D in regulation of alveolar homeostasis. Am J Physiol Lung Cell Mol Physiol (2006) 0.90

Pulmonary collectins selectively permeabilize model bacterial membranes containing rough lipopolysaccharide. Biochemistry (2006) 0.89

M.I.T./Canadian vestibular experiments on the Spacelab-1 mission: 1. Sensory adaptation to weightlessness and readaptation to one-g: an overview. Exp Brain Res (1986) 0.89

St. George's Respiratory Questionnaire has longitudinal construct validity in lymphangioleiomyomatosis. Chest (2013) 0.89

Interactions of pulmonary collectins with Bordetella bronchiseptica and Bordetella pertussis lipopolysaccharide elucidate the structural basis of their antimicrobial activities. Infect Immun (2004) 0.89

Surfactant protein A modulates cell surface expression of CR3 on alveolar macrophages and enhances CR3-mediated phagocytosis. J Biol Chem (2009) 0.88

Pleural disease in lymphangioleiomyomatosis. Clin Chest Med (2006) 0.87

Orientation illusions and heart-rate changes during short-radius centrifugation. J Vestib Res (2001) 0.87

Perception of linear acceleration in weightlessness. Aviat Space Environ Med (1990) 0.86

The role of pulmonary collectin N-terminal domains in surfactant structure, function, and homeostasis in vivo. J Biol Chem (2002) 0.86

Diffusion-based MR methods for bone structure and evolution. Magn Reson Med (2008) 0.86

Crystallographic complexes of surfactant protein A and carbohydrates reveal ligand-induced conformational change. J Biol Chem (2010) 0.85

Kaposiform lymphangiomatosis, a newly characterized vascular anomaly presenting with hemoptysis in an adult woman. Ann Am Thorac Soc (2014) 0.84

Pulmonary surfactant protein-A (SP-A) restores the surface properties of surfactant after oxidation by a mechanism that requires the Cys6 interchain disulfide bond and the phospholipid binding domain. J Biol Chem (2003) 0.84

Ernst Mach on the vestibular organ 100 years ago. ORL J Otorhinolaryngol Relat Spec (1975) 0.84

Interaction of optokinetic and vestibular stimuli in motion perception. Acta Otolaryngol (1973) 0.84

Influence of head orientation on visually induced pitch and roll sensation. Aviat Space Environ Med (1975) 0.84

G-CSF drives a posttraumatic immune program that protects the host from infection. J Immunol (2014) 0.83

MITNYS. A hybrid program for on-line analysis of nystagmus. Aerosp Med (1971) 0.83

Three dimensional eye movements of squirrel monkeys following postrotatory tilt. J Vestib Res (1993) 0.83

Pulmonary surfactant protein A activates a phosphatidylinositol 3-kinase/calcium signal transduction pathway in human macrophages: participation in the up-regulation of mannose receptor activity. J Immunol (2005) 0.83

Automated algorithm for quantifying the extent of cystic change on volumetric chest CT: initial results in Lymphangioleiomyomatosis. AJR Am J Roentgenol (2009) 0.83

Premenstrual changes: a comparison of five populations. Psychiatry Res (1986) 0.82

Endobronchial Carcinoid Tumor in an HIV-infected Patient. J Bronchology Interv Pulmonol (2010) 0.82

The dynamic contributions of the otolith organs to human ocular torsion. Exp Brain Res (1996) 0.82

Surfactant protein A inhibits lipopolysaccharide-induced in vivo production of interleukin-10 by mononuclear phagocytes during lung inflammation. Am J Respir Cell Mol Biol (2003) 0.81

Neurovestibular effects of bed rest and centrifugation. J Vestib Res (2010) 0.81

Clinical trials for rare lung diseases: lessons from lymphangioleiomyomatosis. Lymphat Res Biol (2010) 0.81

Vitamin D deficiency and reduced lung function in connective tissue-associated interstitial lung diseases. Chest (2010) 0.81

Quality-of-life issues in head and neck cancer. Curr Oncol Rep (1999) 0.81

M.I.T./Canadian vestibular experiments on the Spacelab-1 mission: 2. Visual vestibular tilt interaction in weightlessness. Exp Brain Res (1986) 0.81

Frequency response of the vestibulo-ocular reflex (VOR) in the monkey. Aviat Space Environ Med (1981) 0.80

Utility of transbronchial biopsy in the diagnosis of lymphangioleiomyomatosis. Front Med (2012) 0.80

Screening for lymphangioleiomyomatosis by high-resolution computed tomography in young, nonsmoking women presenting with spontaneous pneumothorax is cost-effective. Am J Respir Crit Care Med (2010) 0.80

Sensation of rotation about a vertical axis with a fixed visual field in different illuminations and in the dark. Exp Brain Res (1981) 0.80

Patient perspectives on management of pneumothorax in lymphangioleiomyomatosis. Chest (2006) 0.80

Successful management of a chronic, refractory bronchopleural fistula with endobronchial valves followed by talc pleurodesis. Am J Respir Crit Care Med (2014) 0.80

Influence of visual and motion cues on manual lateral stabilization. Aviat Space Environ Med (1987) 0.80

Measurement of torsion from multitemporal images of the eye using digital signal processing techniques. IEEE Trans Biomed Eng (1985) 0.80

Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management. Am J Respir Crit Care Med (2016) 0.80

Visual-vestibular interaction in motion perception and the generation of nystagmus. Neurosci Res Program Bull (1980) 0.79

Perception of static orientation in a constant gravitoinertial environment. Aviat Space Environ Med (1976) 0.79

A fast-reacting and versatile optokinetic stimulus pattern by computer graphics with application examples. IEEE Trans Biomed Eng (1979) 0.78

Oral administration of surfactant protein-a reduces pathology in an experimental model of necrotizing enterocolitis. J Pediatr Gastroenterol Nutr (2015) 0.78